(Total Views: 417)
Posted On: 02/14/2020 12:17:06 PM
Post# of 154115
Misiu,
In the communication it says:
This is what some of us don't understand. If the numbers have not changed she must have had 0 CTC to start with.
However I think this is unlikely and a clarification from CYDY would be handy.
In any case, great results otherwise in the communication !!!
In the communication it says:
Quote:
“The patients enrolled in the mTNBC Phase 1b/2 trial continue to demonstrate meaningful results that support the hypothesis regarding leronlimab’s mechanism of action,” said Bruce Patterson, M.D., chief executive officer and founder of IncellDx, a diagnostic partner and an advisor to CytoDyn. “In the four patients (1 with MBC, 3 with TNBC) now with results from leronlimab therapy, patients #1-3 have zero CTCs and zero EMTs and Patient #4, who has been treated with leronlimab for 2 weeks showed a decrease of CTCs and EMTs from 8 to 2. New data from Patient #2 with Stage 4 MBC and who has been treated with 10 weekly doses of leronlimab showed zero CTCs and zero EMTs, in addition to the shrinkage or disappearance of some brain metastases as previously reported.”
This is what some of us don't understand. If the numbers have not changed she must have had 0 CTC to start with.
However I think this is unlikely and a clarification from CYDY would be handy.
In any case, great results otherwise in the communication !!!
(0)
(0)
